Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction

Recruiting now · Early Phase 1 · Has a placebo group

Conditions studied: Type 2 Diabetes, Healthy Aging

In brief

The goal of this clinical trial is to examine the role of autophagy on microvascular function in adults with Type 2 Diabetes. The main question it aims to answer are: * Does presence of Type 2 Diabetes reduce autophagy and impair microvascular function? * Does exposure to high glucose impair autophagy and subsequently microvascular function? Participants will undergo 2 study days. The primary outcome will be in vivo microvascular function testing. Following the first study day participants will undergo either supplementation with trehalose, an autophagy activator, or placebo for 14 days. The second study day will test in vivo microvascular function.

Key facts

Study ID
NCT05593549
Run by
Medical College of Wisconsin
People needed
60
Starts
2023-01-01
Expected to finish
2029-12-31
Last updated by the study team
2025-10-30

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.